Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis
IMC Chamber of Commerce and Industry honours Mr. Harish Mehta, Founder, Onward Technologies Ltd for his contribution in Technology
